A. C. Mackinnon

Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function.

K. Dhaliwal, C. Haslett, A. MacKinnon, 2008, The American journal of pathology.

Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.

Sarah L. Farnworth, H. Leffler, Michael A Gibbons, 2012, American journal of respiratory and critical care medicine.

Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis

T. Maher, P. Molyneaux, A. MacKinnon, 2020, European Respiratory Journal.

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase

R. Rintoul, C. Haslett, T. Sethi, 2006, Cell Death and Differentiation.

Defining the mechanism of galectin-3–mediated TGF-β1 activation and its role in lung fibrosis

F. Zetterberg, Panayiota Stylianou, R. G. Jenkins, 2023, bioRxiv.

Galectin-3: therapeutic targeting in liver disease

Massimo Pinzani, D. Tonev, A. C. Mackinnon, 2023, Expert opinion on therapeutic targets.